MicroRNAs as biomarkers of cervical cancer development: A literature review on miR-125b and miR-34a

Molecular Biology Reports

Volumn 41, Issue 3, 2014, Pages 1525-1531

  Ribeiro, Joana ^a,b,c   Sousa, Hugo ^b  

^a University of Porto   (Portugal)

^b PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^c Portuguese League Against Epilepsy   (Portugal)

Author keywords

Biomarkers; Cervical cancer; HPV infection; miR 125b; miR 34a

Indexed keywords

MICRORNA 125B; MICRORNA 34A; TUMOR MARKER;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CANCER PROGNOSIS; HUMAN; PAPILLOMAVIRUS INFECTION; TUMOR IMMUNITY; UTERINE CERVIX CANCER; VIRUS CARCINOGENESIS;

HUMAN PAPILLOMAVIRUS;

APOPTOSIS; CARCINOGENESIS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; SIGNAL TRANSDUCTION; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS;

EID: 84896030058     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-013-2998-0     Document Type: Article

References (70)

1. Jemal A et al (2011) Global cancer statistics. CA Cancer J Clin 61(2):69-90
2. Sankaranarayanan R, Ferlay J (2006) Worldwide burden of gynaecological cancer: the size of the problem. Best Pract Res Clin Obstet Gynaecol 20(2):207-225 (Pubitemid 43380597)
3. Frazer IH (2004) Prevention of cervical cancer through papillomavirus vaccination. Nat Rev Immunol 4(1):46-54
4. Franco EL (2009) A new generation of studies of human papillomavirus DNA testing in cervical cancer screening. J Natl Cancer Inst 101(23):1600-1601
5. Zur Hausen H (2009) The search for infectious causes of human cancers: where and why. Virology 392(1):1-10
6. Ramanakumar AV et al (2010) Human papillomavirus (HPV) types 16, 18, 31, 45 DNA loads and HPV-16 integration in persistent and transient infections in young women. BMC Infect Dis 10:326
7. Hwang SJ, Shroyer KR (2012) Biomarkers of cervical dysplasia and carcinoma. J Oncol 2012:507286
8. Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 7(1):11-22 (Pubitemid 46020844)
9. Sousa H et al (2007) Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20(5):731-741
10. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75(5):843-854 (Pubitemid 24014542)
11. Malumbres M (2012) miRNAs versus oncogenes: the power of social networking. Mol Syst Biol 8:569
12. Lagos-Quintana M et al (2001) Identification of novel genes coding for small expressed RNAs. Science 294(5543):853-858 (Pubitemid 33032103)
13. Lau NC et al (2001) An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 294(5543):858-862 (Pubitemid 33032104)
14. Lujambio A, Lowe SW (2012) The microcosmos of cancer. Nature 482(7385):347-355
15. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2):281-297
16. Wightman B, Ha I, Ruvkun G (1993) Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans . Cell 75(5):855-862 (Pubitemid 24014543)
17. Melo SA, Esteller M (2011) Dysregulation of microRNAs in cancer: playing with fire. FEBS Lett 585(13):2087-2099
18. Kong YW et al (2012) microRNAs in cancer management. Lancet Oncol 13(6):e249-e258
19. Pritchard CC, Cheng HH, Tewari M (2012) MicroRNA profiling: approaches and considerations. Nat Rev Genet 13(5):358-369
20. Tili E et al (2008) MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 4(10):534-541
21. Wang N et al (2009) Role of microRNAs in cardiac hypertrophy and heart failure. IUBMB Life 61(6):566-571
22. Lu J et al (2005) MicroRNA expression profiles classify human cancers. Nature 435(7043):834-838 (Pubitemid 40839735)
23. Hermeking H (2012) MicroRNAs in the p53 network: micromanagement of tumour suppression. Nat Rev Cancer 12(9):613-626
24. Pereira PM et al (2010) MicroRNA expression variability in human cervical tissues. PLoS One 5(7):e11780
25. He L et al (2007) A microRNA component of the p53 tumour suppressor network. Nature 447(7148):1130-1134 (Pubitemid 47014436)
26. He X, He L, Hannon GJ (2007) The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res 67(23):11099-11101 (Pubitemid 350248530)
27. Martinez I et al (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27(18):2575-2582 (Pubitemid 351550884)
28. Nambaru L et al (2009) Prognostic significance of HPV physical status and integration sites in cervical cancer. Asian Pac J Cancer Prev 10(3):355-360
29. Wang X et al (2008) Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 3(7):e2557
30. Li BH et al (2011) Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein. Eur J Cancer 47(14):2166-2174
31. Li Y et al (2011) Progressive miRNA expression profiles in cervical carcinogenesis and identification of HPV-related target genes for miR-29. J Pathol 224(4):484-495
32. Greco D et al (2011) Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 6(7):e21646
33. O'Connell RM, Zhao JL, Rao DS (2011) MicroRNA function in myeloid biology. Blood 118(11):2960-2969
34. Jia HY et al (2012) MicroRNA-125b functions as a tumor suppressor in hepatocellular carcinoma cells. Int J Mol Sci 13(7):8762-8774
35. Le MT et al (2009) MicroRNA-125b is a novel negative regulator of p53. Genes Dev 23(7):862-876
36. Zhang Y et al (2011) miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. Cancer Res 71(10):3552-3562
37. Chaudhuri AA et al (2012) Oncomir miR-125b regulates hematopoiesis by targeting the gene Lin28A. Proc Natl Acad Sci USA 109(11):4233-4238
38. Zhao A et al (2012) MicroRNA-125b induces cancer cell apoptosis through suppression of Bcl-2 expression. J Genet Genomics 39(1):29-35
39. Pang Y, Young CY, Yuan H (2010) MicroRNAs and prostate cancer. Acta Biochim Biophys Sin (Shanghai) 42(6):363-369
40. Visone R et al (2007) Specific microRNAs are downregulated in human thyroid anaplastic carcinomas. Oncogene 26(54):7590-7595 (Pubitemid 350207711)
41. Zhou M et al (2010) MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of proapoptotic Bcl-2 antagonist killer 1 (Bak1) expression. J Biol Chem 285(28):21496-21507
42. Gong J et al (2013) MicroRNA-125b promotes apoptosis by regulating the expression of Mcl-1, Bcl-w and IL-6R. Oncogene 32(25):3071-3079
43. Scott GK et al (2007) Coordinate suppression of ERBB2 and ERBB3 by enforced expression of micro-RNA miR-125a or miR-125b. J Biol Chem 282(2):1479-1486 (Pubitemid 47076526)
44. Nicolete LD et al (2012) Upregulation of hsa-miR-125b in HTLV-1 asymptomatic carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis patients. Mem Inst Oswaldo Cruz 107(6):824-827
45. Witwer KW et al (2012) Relationships of PBMC microRNA expression, plasma viral load, and CD4+ T-cell count in HIV-1-infected elite suppressors and viremic patients. Retrovirology 9:5
46. Nuovo GJ et al (2010) Strong inverse correlation between microRNA-125b and human papillomavirus DNA in productive infection. Diagn Mol Pathol 19(3):135-143
47. Bommer GT et al (2007) p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr Biol 17(15):1298-1307 (Pubitemid 47176893)
48. Chang TC et al (2007) Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26(5):745-752
49. Corney DC et al (2007) MicroRNA-34b and microRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67(18):8433-8438 (Pubitemid 47437414)
50. Tanaka N et al (2012) Frequent methylation and oncogenic role of microRNA-34b/c in small-cell lung cancer. Lung Cancer 76(1):32-38
51. Corney DC et al (2010) Frequent downregulation of miR-34 family in human ovarian cancers. Clin Cancer Res 16(4):1119-1128
52. Vogt M et al (2011) Frequent concomitant inactivation of miR-34a and miR-34b/c by CpG methylation in colorectal, pancreatic, mammary, ovarian, urothelial, and renal cell carcinomas and soft tissue sarcomas. Virchows Arch 458(3):313-322
53. Wang X et al (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15(4):637-647
54. Li B et al (2010) Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 20(4):597-604
55. Johnson CD et al (2007) The let-7 microRNA represses cell proliferation pathways in human cells. Cancer Res 67(16):7713-7722 (Pubitemid 47281364)
56. Akao Y, Nakagawa Y, Naoe T (2006) let-7 microRNA functions as a potential growth suppressor in human colon cancer cells. Biol Pharm Bull 29(5):903-906
57. Tan HX et al (2010) MicroRNA-9 reduces cell invasion and E-cadherin secretion in SK-Hep-1 cell. Med Oncol 27(3):654-660
58. Cimmino A et al (2005) miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 102(39):13944-13949 (Pubitemid 41377683)
59. Guo CJ et al (2009) miR-15b and miR-16 are implicated in activation of the rat hepatic stellate cell: an essential role for apoptosis. J Hepatol 50(4):766-778
60. Song L et al (2011) miR-18a impairs DNA damage response through downregulation of ataxia telangiectasia mutated (ATM) kinase. PLoS One 6(9):e25454
61. Zhong Z et al (2012) miR-21 induces cell cycle at S phase and modulates cell proliferation by down-regulating hMSH2 in lung cancer. J Cancer Res Clin Oncol 138(10):1781-1788
62. Jin Y (2011) 3,3′-Diindolylmethane inhibits breast cancer cell growth via miR-21-mediated Cdc25A degradation. Mol Cell Biochem 358(1-2):345-354
63. Si ML et al (2007) miR-21-mediated tumor growth. Oncogene 26(19):2799-2803
64. Silber J et al (2008) miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med 6:14
65. Kozaki K et al (2008) Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer. Cancer Res 68(7):2094-2105 (Pubitemid 351521781)
66. Bhaumik D et al (2008) Expression of microRNA-146 suppresses NF-kappaB activity with reduction of metastatic potential in breast cancer cells. Oncogene 27(42):5643-5647
67. Piovan C et al (2012) Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol 6(4):458-472
68. Kim YK et al (2009) Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 37(5):1672-1681
69. Hu H, Gatti RA (2011) MicroRNAs: new players in the DNA damage response. J Mol Cell Biol 3(3):151-158
70. Hu W et al (2010) Negative regulation of tumor suppressor p53 by microRNA miR-504. Mol Cell 38(5):689-699